•  
  •  
 

Journal of Metals, Materials and Minerals

Publication Date

2025

Abstract

The emergence of the SARS-CoV-2 variant XBB.1.5 has triggered a global health crisis by enhancing viral entry into cells via its spike protein. This study addresses the urgent need to develop neutralizing nanobodies (Nbs) to counteract the SARS-CoV-2 virus. Our aim was to identify a lead Nb and enhance its binding affinity to the receptor-binding motif (RBM) on the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein (S-protein) using computational methods. A total of 29 Nbs were screened against the XBB.1.5 RBD using the HDOCK server to select a lead Nb. This investigation revealed that Nb_7KGK exhibited the highest binding affinity. Subsequently, unfavorable residues of Nb_7KGK were mutated to further enhance binding affinity. As expected, aromatic residues (tyrosine, tryptophan, histidine) were primarily mutated to improve binding affinity, resulting in a new Nb variant named Nb_7KGK(7), with heightened affinity. The engineered Nb_7KGK(7) demonstrated improved chemical interactions with the RBD. Predicted physicochemical properties, such as pI value, total charge, Clashscore, and MolProbity score of the engineered Nb, were also improved. This study highlights the potential of computational design as a preliminary step toward developing effective Nbs against the emerging SARS-CoV-2 XBB.1.5 variant.

DOI

10.55713/jmmm.v35i2.2184

First Page

-

Last Page

-

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.